Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment

LD Wood, MI Canto, EM Jaffee, DM Simeone - Gastroenterology, 2022 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is a clinically challenging cancer, due to both its
late stage at diagnosis and its resistance to chemotherapy. However, recent advances in our …

Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis

J Cai, H Chen, M Lu, Y Zhang, B Lu, L You, T Zhang… - Cancer letters, 2021 - Elsevier
Pancreatic cancer is a malignancy with poor prognosis and high mortality. The recent
increase in pancreatic cancer incidence and mortality has resulted in an increased number …

Burden of pancreatic cancer: from epidemiology to practice

N Khalaf, HB El-Serag, HR Abrams, AP Thrift - Clinical Gastroenterology …, 2021 - Elsevier
Pancreatic cancer is the seventh leading cause of cancer-related deaths worldwide with
432,242 related deaths in 2018. Unlike other cancers, the incidence of pancreatic cancer …

Pancreatic adenocarcinoma

DP Ryan, TS Hong, N Bardeesy - New England Journal of …, 2014 - Mass Medical Soc
Pancreatic Adenocarcinoma | NEJM Skip to main content NEJM Group Follow Us Facebook
Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge …

Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance

MI Canto, JA Almario, RD Schulick, CJ Yeo, A Klein… - Gastroenterology, 2018 - Elsevier
Background & Aims Screening of individuals who have a high risk of pancreatic ductal
adenocarcinoma (PDAC), because of genetic factors, frequently leads to identification of …

The epidemiology of pancreatitis and pancreatic cancer

D Yadav, AB Lowenfels - Gastroenterology, 2013 - Elsevier
Acute pancreatitis is one of the most frequent gastrointestinal causes of hospital admission
in the United States. Chronic pancreatitis, although lower in incidence, significantly reduces …

[HTML][HTML] Pancreatic ductal adenocarcinoma: Epidemiology and risk factors

J Ushio, A Kanno, E Ikeda, K Ando, H Nagai, T Miwata… - Diagnostics, 2021 - mdpi.com
The number of new cases of pancreatic ductal adenocarcinoma is increasing with a
cumulative total of 495,773 cases worldwide, making it the fourteenth most common …

Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection

S Raimondi, AB Lowenfels, AM Morselli-Labate… - Best practice & research …, 2010 - Elsevier
Acute pancreatitis, chronic pancreatitis and pancreatic cancer are responsible for most of the
burden of exocrine pancreatic disease. Glandular damage from recurrent bouts of acute …

Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis

J Mayerle, H Kalthoff, R Reszka, B Kamlage, E Peter… - Gut, 2018 - gut.bmj.com
Objective Current non-invasive diagnostic tests can distinguish between pancreatic cancer
(pancreatic ductal adenocarcinoma (PDAC)) and chronic pancreatitis (CP) in only about two …

Epidemiology of pancreatic cancer: an overview

S Raimondi, P Maisonneuve… - … reviews Gastroenterology & …, 2009 - nature.com
Pancreatic cancer, although infrequent, has an exceptionally high mortality rate, making it
one of the four or five most common causes of cancer mortality in developed countries. The …